Ads
related to: sio gene therapiesmrna.creative-biolabs.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Sio Gene Therapies, Inc. (formerly known as Axovant Gene Therapies) was a clinical-stage pharmaceutical company that developed gene therapies to treat neurological disorders. The company was headquartered in New York City and was incorporated in Basel, Switzerland. The company was founded by former hedge fund analyst and 2024 Republican Party ...
Sio Gene Therapies Inc (NASDAQ: SIOX) has dosed the first patient in Phase 1/2 trial evaluating AXO-AAV-GM2 investigational gene therapy to treat GM2 gangliosidosis, also known as Tay-Sachs or ...
908 (2024) Website. roivant .com. Footnotes / references. Financials as of 31 March 2024. [update] . [ 1][ 2] Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy.
Vivek Ganapathy Ramaswamy ( / vɪˈveɪk rɑːməˈswɑːmiː /; [ 1][ 2] vih-VAYK rah-mə-SWAH-mee; born August 9, 1985) is an American entrepreneur. He founded Roivant Sciences, a pharmaceutical company, in 2014. In February 2023, Ramaswamy declared his candidacy for the Republican Party nomination in the 2024 United States presidential election.
Experimental options discussed at the San Diego meeting included personalized treatments and next-generation gene therapies, many still in the earliest stages of testing. People with hemophilia ...
Takeaways from AP's report on access to gene therapies for rare diseases. LAURA UNGAR. June 21, 2024 at 12:42 AM. The promise of gene therapy looms large for families dealing with rare, genetic ...
Ads
related to: sio gene therapiesmrna.creative-biolabs.com has been visited by 10K+ users in the past month